Nasacort AQ (triamcinolone acetonide) Nasal Spray

Company
Phone-Poulenc Rorer

Approval Status
Approved October 1997

Treatment for
allergic rhinitis

Possible similar drugs
Nasacort AQ

Areas
Pediatrics , Respiratory

Nasacort (R) AQ (triamcinolone acetonide) has been approved by the U.S. Food and Drug Administration (FDA) for use the treatment of nasal symptoms of seasonal and perennial allergic rhinitis in children aged 6-11. Nasacort in currently available in the U.S. for adults and children aged 12 years and older.

Nasacort_aq_317 Drug Information

The Nasacort_aq_317 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top